Navidea Biopharmaceuticals, Inc. (NAVBQ)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Aug 28, 16:00
More

Navidea Biopharmaceuticals Price to Book Value

Price to Book Value Chart

View Price to Book Value for NAVBQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 1999. Start Trial.
Date Value
December 30, 2021 9.219
December 29, 2021 9.130
December 28, 2021 9.574
December 27, 2021 9.574
December 23, 2021 10.11
December 22, 2021 10.02
December 21, 2021 10.28
December 20, 2021 10.90
December 17, 2021 11.44
December 16, 2021 10.73
December 15, 2021 10.28
December 14, 2021 10.99
December 13, 2021 11.35
December 10, 2021 10.46
December 09, 2021 10.37
December 08, 2021 11.08
December 07, 2021 10.02
December 06, 2021 10.11
December 03, 2021 10.19
December 02, 2021 10.81
December 01, 2021 10.64
November 30, 2021 10.90
November 29, 2021 11.17
November 26, 2021 11.52
November 24, 2021 11.35
Date Value
November 23, 2021 11.26
November 22, 2021 11.70
November 19, 2021 11.35
November 18, 2021 11.61
November 17, 2021 12.14
November 16, 2021 12.50
November 15, 2021 12.14
November 12, 2021 11.70
November 11, 2021 12.68
November 10, 2021 12.76
November 09, 2021 12.41
November 08, 2021 12.94
November 05, 2021 13.21
November 04, 2021 13.21
November 03, 2021 13.39
November 02, 2021 13.12
November 01, 2021 13.47
October 29, 2021 13.39
October 28, 2021 13.74
October 27, 2021 13.74
October 26, 2021 14.89
October 25, 2021 14.72
October 22, 2021 15.16
October 21, 2021 15.25
October 20, 2021 15.78

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Infinity Pharmaceuticals, Inc. --
Adynxx, Inc. --
OncoSec Medical, Inc. --
Proteonomix, Inc. --
Rebus Holdings, Inc. --

Price to Book Value Related Metrics

Price 0.0000
Market Cap 0.0001M